Regarding glucose metabolism, a meta-analysis of 12 clinical trials showed that melatonin administration reduced fasting blood glucose, but had no influence on levels of glycated hemoglobin, insulin or insulin resistance (IR) (31). This evidence concerns the gene INS and Insulin resistance.